Status:
UNKNOWN
Impact of Visual Field Restriction on Visual Exploration
Lead Sponsor:
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Conditions:
Pigmentary Retinopathy
Eligibility:
All Genders
18-65 years
Brief Summary
To communicate with the observer and guide his gaze on the canvas, painters have developed different stylistic processes that artists, in the manner of scientists, have acquired on the functioning of ...
Detailed Description
In this experiment, the investigators study the adaptive strategies developed by people with retinitis pigmentosa in the perception of figurative works of art. Peripheral vision is crucial for detecti...
Eligibility Criteria
Inclusion
- Groupe 1
- no visual pathology
- Age ≥ 18 and \<65 years
- Binocular visual acuity ≥8 / 10th or ≤ +0.10 logMAR
- Comprehension of the written and spoken French language
- Signed consent to participate in the study
- Health insurance affiliation
- Visit to an ophthalmologist less than a year old
Exclusion
- Pregnant or lactating woman
- Ocular pathology that may interfere with planned assessments
- Treatment that may interfere with planned assessments
- Participation in another study that may interfere with this study.
- Severe pathology unbalanced or interfering with planned assessments.
- Neurological deficit including history of epileptic pathology, photosensitive epilepsy, sensory-motor coordination disorders, vestibular or cerebellar pathology
- Inability to give consent personally.
- Adults protected by law.
- Groupe 2
- Inclusion Criteria:
- Retinopathy pigmentary dystrophy rods-cones.
- Binocular visual acuity ≥4 / 10 (≤0.4 logMAR).
- Horizontal diameter of the residual Goldmann field of view ≤ 25 ° of binocular diameter at III4.
- Comprehension of the French language, written or oral.
- Signed consent
- Visual assessment less than 6 months old
Key Trial Info
Start Date :
November 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 17 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04360291
Start Date
November 4 2019
End Date
October 17 2021
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de la vision
Paris, France, 75012